Skip to content

Impact of a Non-Drug Choice on Cocaine Reinforcement

Impact of a Non-Drug Choice on Cocaine Reinforcement

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01906346
Enrollment
9
Registered
2013-07-24
Start date
2014-01-31
Completion date
2015-06-30
Last updated
2019-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine Dependence

Brief summary

Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-administration procedures and a non-drug alternative reinforcer, which is hypothesized to reduce the reinforcing effects of cocaine.

Interventions

DRUGCocaine

Three active doses of cocaine will be made available for self-administration during experimental sessions.

DRUGPlacebo

Placebo cocaine will be made available for self-administration during experimental sessions.

Sponsors

Joshua A. Lile, Ph.D.
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Cocaine dependence, otherwise healthy

Exclusion criteria

* Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease

Design outcomes

Primary

MeasureTime frameDescription
The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative9 choice trials per cocaine dose level with each trial separated by 30 minutesThe reinforcing effects of cocaine were determined using a modified progressive ratio procedure in which subjects made 9 choices between each available cocaine dose and one of three money alternatives.

Countries

United States

Participant flow

Participants by arm

ArmCount
Randomized Combination of One Drug Dose and One Money Value
Low, medium and high value monetary reinforcers are made available as an alternative to cocaine and placebo during experimental sessions. Cocaine: Three active doses of cocaine are made available for self-administration during experimental sessions. Placebo: Placebo cocaine is made available for self-administration during experimental sessions.
9
Total9

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAEs1

Baseline characteristics

CharacteristicRandomized Combination of One Drug Dose and One Money Value
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
Region of Enrollment
United States
9 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 9
other
Total, other adverse events
1 / 9
serious
Total, serious adverse events
0 / 9

Outcome results

Primary

The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative

The reinforcing effects of cocaine were determined using a modified progressive ratio procedure in which subjects made 9 choices between each available cocaine dose and one of three money alternatives.

Time frame: 9 choice trials per cocaine dose level with each trial separated by 30 minutes

ArmMeasureGroupValue (MEAN)Dispersion
Low Value Alternative ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward AlternativePlacebo Cocaine2.75 cocaine choicesStandard Error 1.39
Low Value Alternative ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative3 mg/70 kg Cocaine4.75 cocaine choicesStandard Error 1.24
Low Value Alternative ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative10 mg/70 kg Cocaine7.38 cocaine choicesStandard Error 1.07
Low Value Alternative ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative30 mg/70kg Cocaine7.63 cocaine choicesStandard Error 1.12
Medium Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative30 mg/70kg Cocaine7.13 cocaine choicesStandard Error 1.13
Medium Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward AlternativePlacebo Cocaine1.38 cocaine choicesStandard Error 0.53
Medium Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative10 mg/70 kg Cocaine6.13 cocaine choicesStandard Error 1.47
Medium Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative3 mg/70 kg Cocaine5.88 cocaine choicesStandard Error 1.17
High Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative30 mg/70kg Cocaine6.38 cocaine choicesStandard Error 1.22
High Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative3 mg/70 kg Cocaine4.00 cocaine choicesStandard Error 1.52
High Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative10 mg/70 kg Cocaine6.38 cocaine choicesStandard Error 1.41
High Value ReinforcerThe Number of Times Cocaine Was Selected in the Presence of a Monetary Reward AlternativePlacebo Cocaine1.38 cocaine choicesStandard Error 0.53

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026